A Phase II Study of DAS181, a Novel Host Directed Antiviral for the Treatment of Influenza Infection

Background. DAS181, a novel host-directed antiviral in development for influenza treatment, was assessed in this phase II clinical trial. Methods. This study was a double-blind, placebo-controlled phase II clinical trial assessing influenza viral load and patient safety in otherwise healthy influenz...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Moss, Ronald B., Hansen, Carrie, Sanders, Rebecca L., Hawley, Stephen, Li, Tiejun, Steigbigel, Roy T.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2012
Konular:
Major Articles and Brief Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3570175/
https://ncbi.nlm.nih.gov/pubmed/23045618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis622
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller